logo
#

Latest news with #InflectionPointVentures

Physis Capital raises ₹200 crore, eyes 15+ startup deals by mid-2025
Physis Capital raises ₹200 crore, eyes 15+ startup deals by mid-2025

Business Standard

time2 days ago

  • Business
  • Business Standard

Physis Capital raises ₹200 crore, eyes 15+ startup deals by mid-2025

Growth-stage venture fund Physis Capital on Wednesday announced that it has raised over ₹200 crore for its maiden fund. The fund, established by Vinay Bansal, Ankur Mittal, and Mitesh Shah of Inflection Point Ventures, plans to raise the remaining capital over the next six to nine months. The fund has attracted investors including SUD Life — a joint venture between Bank of India, Union Bank of India, and Japan's Dai-ichi Life Holdings. Other notable backers include Narayana Nethralaya, a NABH-accredited eye care institution in Bengaluru, and family offices such as Haldiram's and Lotus Holdings. Physis Capital plans to build a portfolio of over 15 companies by the first half of next year and aims to invest in high-impact, tech-driven startups in the pre-Series A to Series B stages. So far, the firm has eight deals in the pipeline and is preparing to issue term sheets for at least four of them in the coming months. These investments are expected to close within the next two quarters. The pipeline spans diverse sectors, including health-tech, fintech, consumer brands, and quick commerce, the company said in a statement. The cheque sizes for these companies will range between $1 million and $1.5 million, with a potential top-up of up to $4 million in high-performing portfolio startups. The firm has invested in three companies to date — Ben & Gaws, CTPL, and STAGE. Its most recent investment was in STAGE, a hyperlocal OTT platform creating content in Indian dialects such as Haryanvi, Rajasthani, and Bhojpuri. Vinay Bansal, general partner at the firm, said: 'With strong support from marquee investors and a clear focus on founder-first investing, Physis Capital is well-positioned to back the next wave of high-impact startups in India — partnering with bold, ambitious teams to drive long-term, sustainable growth. We are on track to build a portfolio of 15+ companies by the first half of next year.'

Kisah Apparels raises Rs 13 crore from Wow Momo, others
Kisah Apparels raises Rs 13 crore from Wow Momo, others

Fashion Network

time6 days ago

  • Business
  • Fashion Network

Kisah Apparels raises Rs 13 crore from Wow Momo, others

Men's ethnic wear brand Kisah Apparels has secured Rs 13 crore ($1.52 million) in a pre-series A funding round led by Sagar Daryani, founder of Wow Momo. The round also saw participation from Apoorv Salarpuria, Rahul Todi, Vinod Dugar, and Inflection Point Ventures. The company will utilise the funds to expand its offline footprint, scale its direct-to-consumer (D2C) business, and brand-building initiatives. Kisah claims to have grown from a revenue range of Rs 40 to 45 crore to a current run rate exceeding Rs 100 crore, all while maintaining positive operating cash flow and profitability. The brand's strategic roadmap focuses on expanding touchpoints, strengthening customer loyalty, and building a resilient omnichannel presence. Commenting on the funding, Yash Sarawagi, co-founder CEO of Kisah Apparels in a statement said, 'E-commerce gave us pan-India reach and deep customer insights, which are now fuelling our D2C and offline growth, backed by data, customer pull, and positive cash flow at the company level.' Founded in 2018 by Yash Sarawagi and Yashwi Ladasaria, the Kolkata-based brand offers ethnic wear tailored for Gen Z and millennial consumers. It currently runs two physical stores and plans to open three more across major Indian cities.

Iom Bioworks Raises INR 4 Crore in Seed Round to Advance Microbiome-Based Healthcare
Iom Bioworks Raises INR 4 Crore in Seed Round to Advance Microbiome-Based Healthcare

Entrepreneur

time12-06-2025

  • Business
  • Entrepreneur

Iom Bioworks Raises INR 4 Crore in Seed Round to Advance Microbiome-Based Healthcare

Iom Bioworks aims to personalize health by analyzing and modulating key gut bacteria to support digestion, immunity, metabolism, and overall well-being You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Iom Bioworks, a science-driven healthtech startup focused on microbiome-centered wellness, has raised INR 4 crore in Seed Round funding, led by Inflection Point Ventures (IPV). According to a press release by the company, the capital will be used to ramp up marketing efforts, secure intellectual property, build infrastructure, and expand both scientific and commercial teams. Founded in 2022, Iom Bioworks aims to personalize health by analyzing and modulating key gut bacteria to support digestion, immunity, metabolism, and overall well-being. The company's approach integrates artificial intelligence with microbiome science to offer precise and actionable health recommendations. It claims two granted patents and two more nearing completion, with scientific findings published in peer-reviewed journals. Within its first year, the company crossed 500 customers and established logistics infrastructure and digital access across India for its microbiome services. "Iom Bioworks envisions a world where a healthy mind and body are achievable through informed choices that nurture the microbiome," said Bipin Pradeep Kumar, co-founder and CEO. "By empowering our inner ecosystem through prebiotics and a food and lifestyle centred around the bacteria, we aim to energize daily life while preserving the joy of living." Kumar credited the role of their investment partner in supporting the company's growth. "Partnering with IPV has been transformative; their supportive and diligent approach has set us firmly on the path toward this vision," he added. The startup's scientific leadership includes co-founder and chief of science & technology Dr. Samik Ghosh, who leverages computational biology to develop targeted wellness solutions, and Dr. Hiroaki Kitano, co-founder and chief of research & collaboration, an internationally recognized systems biologist and AI researcher. Vinay Bansal, founder of IPV, pointed to the growing relevance of gut health in addressing chronic conditions. "Lifestyle diseases have been on the rise due to multiple reasons like poor diet, stress, lack of sleep and are intimately linked to poor gut health and microbial composition," he said. "Iom Bioworks is making this cutting-edge science accessible, personalised and importantly, actionable."

Alcobev startup Feline Spirits raises Rs 5.2 cr in pre-series A funding led by IPV
Alcobev startup Feline Spirits raises Rs 5.2 cr in pre-series A funding led by IPV

Time of India

time08-05-2025

  • Business
  • Time of India

Alcobev startup Feline Spirits raises Rs 5.2 cr in pre-series A funding led by IPV

New Delhi: Feline Spirits , a craft alcoholic beverage startup, has raised Rs 5.2 crore in a pre-series A funding round led by Inflection Point Ventures (IPV), the company said in a press release on Thursday. The company said to utilize the capital to expand the company's product portfolio and facilitate entry into new markets. Also, the company plans to launch ' Nine Lives Premium Whisky ' to tap into the semi-premium segment. The startup has sold over 4.1 lakh bottles, generating more than Rs 25 crore in sales in FY25, it shared. Founded by Prabhat Sharma (CEO) and Rohit Saxena (COO), the company is currently operational in 10 markets. It holds licenses in eight markets, including five government-operated ones. "As we expand our footprint across the country and strengthen our partnerships, we're excited to lead a transformation in the way consumers engage with and enjoy craft alcohol," the company's CEO said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store